메뉴 건너뛰기




Volumn 23, Issue 15, 2005, Pages 3636-3637

The impact of hormone replacement therapy on the incidence of breast cancer in Norway [5]

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

EID: 20644469698     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.378     Document Type: Letter
Times cited : (6)

References (3)
  • 1
    • 16544362932 scopus 로고    scopus 로고
    • Mammographic screening is dramatically changing age-incidence data for breast cancer
    • Hemminki K, Rawal R, Bermejo J: Mammographic screening is dramatically changing age-incidence data for breast cancer. J Clin Oncol 22:4652-4653, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 4652-4653
    • Hemminki, K.1    Rawal, R.2    Bermejo, J.3
  • 2
    • 1942542421 scopus 로고    scopus 로고
    • Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study
    • Zahl PH, Strand BH, Maehlen J: Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: Prospective cohort study. BMJ 328:921-924, 2004
    • (2004) BMJ , vol.328 , pp. 921-924
    • Zahl, P.H.1    Strand, B.H.2    Maehlen, J.3
  • 3
    • 4544241856 scopus 로고    scopus 로고
    • Hormone replacement therapy and incidence of hormone dependent cancers in the Norwegian Women and Cancer (NOWAC) study
    • Bakken K, Alsaker E, Eggen A, et al: Hormone replacement therapy and incidence of hormone dependent cancers in the Norwegian Women and Cancer (NOWAC) study. Int J Cancer 112:130-134, 2004
    • (2004) Int J Cancer , vol.112 , pp. 130-134
    • Bakken, K.1    Alsaker, E.2    Eggen, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.